Research ArticleMyositis
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease
Tomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui and Takafumi Suda
The Journal of Rheumatology August 2019, 46 (8) 935-942; DOI: https://doi.org/10.3899/jrheum.180825
Tomoyuki Fujisawa
From the Second Division, Department of Internal Medicine, and the Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, Hamamatsu,
Japan.
Hironao Hozumi
Hideki Yasui
Yuzo Suzuki
Masato Karayama
Kazuki Furuhashi
Noriyuki Enomoto
Yutaro Nakamura
Naoki Inui
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 46, Issue 8
1 Aug 2019
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease
Tomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Takafumi Suda
The Journal of Rheumatology Aug 2019, 46 (8) 935-942; DOI: 10.3899/jrheum.180825
Clinical Significance of Serum Chitotriosidase Level in Anti-MDA5 Antibody–positive Dermatomyositis-associated Interstitial Lung Disease
Tomoyuki Fujisawa, Hironao Hozumi, Hideki Yasui, Yuzo Suzuki, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Yutaro Nakamura, Naoki Inui, Takafumi Suda
The Journal of Rheumatology Aug 2019, 46 (8) 935-942; DOI: 10.3899/jrheum.180825